Evotec SE Share Price Other OTC
Stocks
EVTCY
US30050E1055
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 52Cr 59Cr 49Cr 44Cr 83Cr 5.7TCr 84Cr 585.84Cr 226.07Cr 2.9TCr 223.13Cr 218.18Cr 9.32TCr | P/E 2026 * |
-2.48x | P/E 2027 * | -6.77x |
|---|---|---|---|---|---|
| Enterprise Value | 66Cr 76Cr 62Cr 57Cr 106.16Cr 7.27TCr 106.6Cr 747.41Cr 288.42Cr 3.7TCr 284.67Cr 278.35Cr 12TCr | EV / Sales 2026 * |
1.1x | EV / Sales 2027 * | 0.94x |
| Free-Float |
89.91% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Evotec SE
| 1 day | +1.30% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 01/07/2024 | |
| Director of Finance/CFO | - | 01/05/2026 | |
Ingrid Müller
COO | Chief Operating Officer | - | 01/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Roland Sackers
BRD | Director/Board Member | 58 | 19/06/2019 |
| Director/Board Member | 64 | 01/06/2021 | |
Duncan McHale
BRD | Director/Board Member | 59 | 10/06/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.30% | -.--% | - | - | 59Cr | |
| +0.11% | +2.71% | +0.33% | +28.59% | 4.63TCr | |
| -1.12% | +1.78% | +40.07% | +27.26% | 4.39TCr | |
| -3.04% | -6.29% | +322.27% | +517.36% | 4.09TCr | |
| -0.74% | +1.25% | +2.32% | +67.94% | 3.99TCr | |
| -0.50% | +0.67% | +11.79% | +40.51% | 2.95TCr | |
| -0.46% | +4.22% | +21.99% | +124.21% | 1.71TCr | |
| -0.97% | -10.17% | - | - | 1.55TCr | |
| -0.57% | +8.12% | +22.15% | +38.93% | 1.52TCr | |
| -3.14% | +31.91% | -10.60% | - | 1.4TCr | |
| Average | -0.76% | +3.76% | +51.29% | +120.69% | 2.92TCr | |
| Weighted average by Cap. | -1.01% | +1.87% | +64.69% | +130.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60Cr 69Cr 57Cr 52Cr 97Cr 6.61TCr 97Cr 679.63Cr 262.27Cr 3.36TCr 258.86Cr 253.11Cr 11TCr | 72Cr 83Cr 68Cr 62Cr 116.33Cr 7.97TCr 116.81Cr 819Cr 316.05Cr 4.05TCr 311.94Cr 305.01Cr 13TCr |
| Net income | -20Cr -23Cr -19Cr -17Cr -32Cr -2.22TCr -33Cr -228.46Cr -88Cr -1.13TCr -87Cr -85Cr -3.64TCr | -4.83Cr -5.53Cr -4.56Cr -4.14Cr -7.75Cr -530.95Cr -7.78Cr -55Cr -21Cr -269.94Cr -21Cr -20Cr -868.56Cr |
| Net Debt | 14Cr 16Cr 13Cr 12Cr 23Cr 1.57TCr 23Cr 161.57Cr 62Cr 799.19Cr 62Cr 60Cr 2.57TCr | 16Cr 19Cr 15Cr 14Cr 26Cr 1.78TCr 26Cr 183.42Cr 71Cr 907.26Cr 70Cr 68Cr 2.92TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
